Clinical Trial Update: Intravenous (IV) Vitamin C With Chemotherapy for Cisplatin Ineligible Bladder Cancer Patients [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports Phase 1/2 results for intravenous vitamin C combined with chemotherapy in cisplatin-ineligible bladder cancer patients; the s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer

Drugs mentioned

• Vitamin C (ascorbic acid)

Snippet

Sponsor: University of Kansas Medical Center | Conditions: Bladder Cancer | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2024-03-04